Addressing barriers to initiation of insulin in patients with type 2 diabetes.

Mark Peyrot, Richard R. Rubin, Kamlesh Khunti

    Research output: Contribution to journalArticle


    Type 2 diabetes is progressive in nature and many people with the condition will inevitably require insulin therapy to attain and maintain adequate glycaemic control. In clinical practice, insulin initiation is delayed in many patients who would benefit from such treatment. Patients' and physicians' beliefs and perceptions regarding insulin therapy are known to create barriers contributing to the delay in its initiation. This article explores the nature of these barriers and offers suggestions and practical solutions for addressing and overcoming these hurdles so that insulin can be initiated confidently and appropriately in order to improve diabetes care. 2010 Primary Care Diabetes Europe. Published by Elsevier Ltd.. All rights reserved.

    Original languageEnglish (US)
    Pages (from-to)S11-18
    JournalPrimary care diabetes
    Volume4 Suppl 1
    StatePublished - Apr 2010

    ASJC Scopus subject areas

    • Internal Medicine
    • Endocrinology, Diabetes and Metabolism
    • Nutrition and Dietetics

    Fingerprint Dive into the research topics of 'Addressing barriers to initiation of insulin in patients with type 2 diabetes.'. Together they form a unique fingerprint.

  • Cite this